1. Home
  2. VFF vs ALXO Comparison

VFF vs ALXO Comparison

Compare VFF & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VFF
  • ALXO
  • Stock Information
  • Founded
  • VFF 1989
  • ALXO 2015
  • Country
  • VFF Canada
  • ALXO United States
  • Employees
  • VFF N/A
  • ALXO N/A
  • Industry
  • VFF
  • ALXO Biotechnology: Pharmaceutical Preparations
  • Sector
  • VFF
  • ALXO Health Care
  • Exchange
  • VFF Nasdaq
  • ALXO Nasdaq
  • Market Cap
  • VFF 87.5M
  • ALXO 76.5M
  • IPO Year
  • VFF N/A
  • ALXO 2020
  • Fundamental
  • Price
  • VFF $0.73
  • ALXO $1.74
  • Analyst Decision
  • VFF Strong Buy
  • ALXO Buy
  • Analyst Count
  • VFF 2
  • ALXO 6
  • Target Price
  • VFF $1.20
  • ALXO $11.00
  • AVG Volume (30 Days)
  • VFF 427.4K
  • ALXO 1.1M
  • Earning Date
  • VFF 03-12-2025
  • ALXO 03-06-2025
  • Dividend Yield
  • VFF N/A
  • ALXO N/A
  • EPS Growth
  • VFF N/A
  • ALXO N/A
  • EPS
  • VFF N/A
  • ALXO N/A
  • Revenue
  • VFF $327,852,000.00
  • ALXO N/A
  • Revenue This Year
  • VFF $18.02
  • ALXO N/A
  • Revenue Next Year
  • VFF $3.47
  • ALXO N/A
  • P/E Ratio
  • VFF N/A
  • ALXO N/A
  • Revenue Growth
  • VFF 16.74
  • ALXO N/A
  • 52 Week Low
  • VFF $0.58
  • ALXO $1.19
  • 52 Week High
  • VFF $1.62
  • ALXO $17.83
  • Technical
  • Relative Strength Index (RSI)
  • VFF 40.11
  • ALXO 53.13
  • Support Level
  • VFF $0.71
  • ALXO $1.56
  • Resistance Level
  • VFF $0.86
  • ALXO $1.94
  • Average True Range (ATR)
  • VFF 0.04
  • ALXO 0.16
  • MACD
  • VFF -0.01
  • ALXO -0.01
  • Stochastic Oscillator
  • VFF 10.18
  • ALXO 50.00

About VFF Village Farms International Inc.

Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The Company has identified four operating segments - Produce, Cannabis-Canada, Cannabis-U.S. and Energy. The company makes majority of its revenue from the Produce segment.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: